Abstract
Studying host–pathogen interactions at a molecular level has been always technically challenging. Identifying the different biochemical and genetic pathways involved in the different stages of infection traditionally require complex molecular biology tools and often the use of costly animal models. In this chapter we illustrate a complementary approach to address host–pathogen interactions, taking advantage of the natural interindividual genetic diversity. The application of genetic association studies allows us to identify alleles involved in infection progression or resistance. Thus, this strategy may be useful to unravel new molecular pathways underlying host–pathogen interactions. Here we present the general steps that might be followed to plan, execute, and analyze a population-based study in order to identify genetic variants affecting human exposition to pathogens.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cooke GS, Hill AV (2001) Genetics of susceptibility to human infectious disease. Nat Rev Genet 2:967–977
Kimman T (2001) Genetics of infectious disease susceptibility. Springer, Berlin
Dean M, Carrington M, Winkler C et al (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Haemophilia growth and development study, multicenter AIDS cohort study, multicenter Haemophilia cohort study, San Francisco City Cohort, ALIVE study. Science 273:1856–1862
Samson M, Libert F, Doranz BJ et al (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722–725
Fisher A (1918) The correlation between relatives on the supposition of Mendelian inheritance. Trans R Soc Edinburgh 53:399–433
Plomin R, Haworth CM, Davis OS (2009) Common disorders are quantitative traits. Nat Rev Genet 10:872–878
Sugden PB, Cameron B, Luciani F, Lloyd AR (2014) Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users. J Viral Hepat 21:e65–e73
Real LM, Herrero R, Rivero-Juarez A et al (2015) IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection. AIDS 29:1895–1897
Sironi M, Biasin M, Gnudi F et al (2014) A regulatory polymorphism in HAVCR2 modulates susceptibility to HIV-1 infection. PLoS One 9:e106442
McLaren PJ, Coulonges C, Ripke S et al (2013) Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathog 9:e1003515
Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575
Solé X, Guinó E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics Aug 1;22(15):1928–1929
Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678
Gayan J, Gonzalez-Perez A, Bermudo F et al (2008) A method for detecting epistasis in genome-wide studies using case-control multi-locus association analysis. BMC Genomics 9:360
Ionita I, Man M (2006) Optimal two-stage strategy for detecting interacting genes in complex diseases. BMC Genet 7:39
Zhang Y, Liu JS (2007) Bayesian inference of epistatic interactions in case-control studies. Nat Genet 39:1167–1173
Rauch A, Kutalik Z, Descombes P et al (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138:1338–1345
Ge D, Fellay J, Thompson AJ et al (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399–401
Mandorfer M, Neukam K, Reiberger T et al (2013) The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients. AIDS 27:2707–2714
Real LM, Neukam K, Herrero R et al (2014) IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against hepatitis C virus genotype 1 or 4 in Caucasians. PLoS One 9:e95515
Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM et al (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164–171
Band G, Le QS, Jostins L, Pirinen M et al (2013) Imputation-based meta-analysis of severe malaria in three African populations. PLoS Genet 9:e1003509
Jallow M, Teo YY, Small KS et al (2009) Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 41:657–665
Timmann C, Thye T, Vens M et al (2012) Genome-wide association study indicates two novel resistance loci for severe malaria. Nature 489:443–446
Manjurano A, Sepulveda N, Nadjm B et al (2015) USP38, FREM3, SDC1, DDC, and LOC727982 gene polymorphisms and differential susceptibility to severe malaria in Tanzania. J Infect Dis 212:1129–1139
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Royo, J.L., Real, L.M. (2018). Genetic Association Studies in Host–Pathogen Interaction Analysis. In: Medina, C., López-Baena, F. (eds) Host-Pathogen Interactions. Methods in Molecular Biology, vol 1734. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7604-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7604-1_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7603-4
Online ISBN: 978-1-4939-7604-1
eBook Packages: Springer Protocols